These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

812 related items for PubMed ID: 11394497

  • 1. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 2. Antitumor Effect on Murine Renal Cell Carcinoma by Autologous Tumor Vaccines Genetically Modified with Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-6 Cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother (1991); 2001 May; 24(3):205-211. PubMed ID: 11395635
    [Abstract] [Full Text] [Related]

  • 3. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 4. Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer.
    Wysocki PJ, Kazimierczak U, Suchorska W, Kotlarski M, Malicki J, Mackiewicz A.
    Cancer Gene Ther; 2010 Jul 01; 17(7):465-75. PubMed ID: 20168352
    [Abstract] [Full Text] [Related]

  • 5. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G, Hoffmann P, Pouwels M, Zlotta A, Schulman C, Velu T, Bruyns CA.
    J Immunother; 2009 Jul 01; 32(2):140-4. PubMed ID: 19238012
    [Abstract] [Full Text] [Related]

  • 6. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
    Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.
    Cancer Res; 2000 Mar 15; 60(6):1663-70. PubMed ID: 10749137
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity.
    Wang L, Qi X, Sun Y, Liang L, Ju D.
    Cancer Gene Ther; 2002 Oct 15; 9(10):819-24. PubMed ID: 12224022
    [Abstract] [Full Text] [Related]

  • 8. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M, Bubeník J, Mikysková R, Mendoza L, Símová J, Bieblová J, Jandlová T, Jinoch P, Smahel M, Vonka V, Pajtasz-Piasecka E.
    Int J Oncol; 2003 Mar 15; 22(3):691-5. PubMed ID: 12579325
    [Abstract] [Full Text] [Related]

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 10. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 11. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E, Aruga A, Arca MJ, Lee WM, Yang NS, Smith JW, Chang AE.
    Cancer Gene Ther; 1997 Jan 15; 4(3):157-66. PubMed ID: 9171934
    [Abstract] [Full Text] [Related]

  • 12. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C, Liu QG, Yang W, Yao YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 15; 28(2):188-92. PubMed ID: 18250039
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells.
    Qin Z, Noffz G, Mohaupt M, Blankenstein T.
    J Immunol; 1997 Jul 15; 159(2):770-6. PubMed ID: 9218594
    [Abstract] [Full Text] [Related]

  • 14. [The anti-tumor activity of GM-CSF-modified lung cancer cell vaccine and its synergism in combination with chemotherapy].
    Jiang HJ, Ren XB, Li H, Yu JP, Wei F, Ma MQ.
    Zhonghua Zhong Liu Za Zhi; 2007 Nov 15; 29(11):808-12. PubMed ID: 18396635
    [Abstract] [Full Text] [Related]

  • 15. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 15; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor effect of murine renal cell carcinoma cells genetically modified to express B7-1 combined with cytokine secreting fibroblasts.
    Wang J, Nakamoto T, Kasaoka Y, Usui T, Hamada H.
    Hiroshima J Med Sci; 2000 Mar 15; 49(1):73-82. PubMed ID: 10824460
    [Abstract] [Full Text] [Related]

  • 17. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
    Nishitani MA, Sakai T, Ishii K, Zhang M, Nakano Y, Nitta Y, Miyazaki J, Kanayama HO, Kagawa S, Himeno K.
    Cancer Gene Ther; 2002 Feb 15; 9(2):156-63. PubMed ID: 11857033
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy with tumor vaccine increases the survival of hepatoma-bearing mice.
    Chao Y, Shih YL, Cheng HJ, Wei SJ, Chi KH, Yeh SH, Lee SD, Yang WK.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct 15; 62(10):682-9. PubMed ID: 10533297
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

  • 20. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response.
    Lee SG, Heo DS, Yoon SJ, Jee YS, Kang JO, Kim K, Kim CD, Sung MW, Kim NK.
    Anticancer Res; 2000 Oct 15; 20(4):2681-6. PubMed ID: 10953343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.